Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602119 · ClinicalTrials.gov registry record · Phase 1
Intraoperative Imaging of Pulmonary Nodules by OTL38
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 262
- Enrollment target
NCT02602119: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT02602119 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 262 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02602119, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 262 participants
- Enrollment target
Study Summary
The primary end-point of the study is to determine the sensitivity of OTL in identifying lung nodules when excited by an imaging probe. Investigators intend to enroll 300 lung cancer patients in this study. The study is focusing on patients presenting with suspected malignancies of the lung and pleura who are considered to be good surgical candidates.
Interventions
- DRUG OTL38
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2015-05 |
| Est. Completion | 2022-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02602119
The ClinicalTrials.gov registry entry for NCT02602119 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OTL38 is the first listed.
NCT02602119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02602119 about?
NCT02602119 is a clinical study titled "Intraoperative Imaging of Pulmonary Nodules by OTL38". The primary end-point of the study is to determine the sensitivity of OTL in identifying lung nodules when excited by an imaging probe. Investigators intend to enroll 300 lung cancer patients in this study. The study is focusing on patients presenting with suspected malignancies of the lung and pleu...
What is the current status of trial NCT02602119?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 262 participants. The study started on 2015-05. Estimated completion is 2022-05.
What interventions are being tested in trial NCT02602119?
The interventions under investigation include: OTL38 (DRUG).
Who is sponsoring clinical trial NCT02602119?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.